Tranexamic Acid and Rhinoplasty: How Do Different Administration Routes Affect Effectiveness?

Aesthetic plastic surgery 2024 Vol.48(17) p. 3284-3291

Sezen Göktaş S, Yenigün A, Sütcü AO, Özturan O, Tuğrul S

관련 도메인

Abstract

[BACKGROUND] The aim of this study was to evaluate the effectiveness of the intravenous, oral and local application of tranexamic acid in operation time, intraoperative bleeding, postoperative edema and ecchymosis in rhinoplasty.

[METHODS] This was a randomized, double-blinded, prospective study. We included 146 patients who underwent rhinoplasty at the Bezmialem Vakif University Medical Faculty Otorhinolaryngology Clinic between April 2021 and April 2022. The patients were divided into four groups: Group 1 (intravenous TXA), Group 2 (oral TXA), Group 3 (topical TXA), and Group 4 (control). Operation time was recorded. Bleeding volume was measured in the suction chamber and nasopharyngeal pack. Postoperative edema and ecchymosis were evaluated using a scale at the end of the operation, on the 1st, 3rd, and 7th days.

[RESULTS] There was no statistically significant difference between groups in terms of mean operation time (p = 0.894). There was a statistically significant lower mean intraoperative bleeding level in Group 2 from the other groups (p = 0.020). Group 3 had significantly lower scores for postoperative edema than the other groups at the end of the operation, on the 1st, 3rd, and 7th days (p < 0.05), and significantly lower scores for postoperative ecchymosis at the end of the operation (p = 0.013) and on the 3rd day (p = 0.024). Although group 3 had a lower score than the other groups in the ecchymosis measurements on the 1st, and 7th days, no statistically significant results were obtained.

[CONCLUSIONS] Local application of tranexamic acid is founded more beneficial for reducing postoperative edema and ecchymosis in rhinoplasty than intravenous and/or oral applications in this study.

[LEVEL OF EVIDENCE I] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 rhinoplasty 코성형술 dict 4
약물 tranexamic acid 트라넥삼산 dict 3
약물 txa 트라넥삼산 dict 3
해부 intravenous scispacy 1
해부 oral scispacy 1
해부 intravenous TXA), scispacy 1
해부 oral TXA scispacy 1
합병증 edema scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 intraoperative bleeding scispacy 1
질환 postoperative edema scispacy 1
질환 ecchymosis C0013491
Ecchymosis
scispacy 1
질환 Bleeding C0019080
Hemorrhage
scispacy 1
질환 nasopharyngeal scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Tranexamic Acid; Rhinoplasty; Female; Double-Blind Method; Antifibrinolytic Agents; Prospective Studies; Male; Adult; Blood Loss, Surgical; Ecchymosis; Treatment Outcome; Edema; Young Adult; Administration, Oral; Operative Time; Administration, Topical; Postoperative Complications

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문